Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

Open access
García-Revilla, Juan, Boza-Serrano, Antonio, Espinosa-Oliva, Ana M., Soto, Manuel Sarmiento, Deierborg, Tomas, Ruiz, Rocío, de Pablos, Rocío M., Burguillos, Miguel Angel, Venero, Jose L. · 2022 · Cell Death & Disease

Abstract

The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of these activated phenotypes is the upregulation of galectin-3. Representative examples of these phenotypes include disease-associated microglia (DAM) and white-associated microglia (WAM), whose role(s) in neuroprotection/neurotoxicity is a matter of high interest in the microglia community. In this review, we summarise the main findings that demonstrate the ability of galectin-3 to interact with key pattern recognition receptors, including, among others, TLR4 and TREM2 and the importance of galectin-3 in the regulation of microglia activation. Finally, we discuss increasing evidence supporting the involvement of this lectin in the main neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, and stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-022-05058-3

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Illustration from Burguillos et al. 2015 [31]: Gal-3 acts as a ligand to TLR4. Left panel: Colocalisation of Gal-3 and TLR4 in BV2 cells after 1 h exposure with sGal-3 protein. Right panel: Microscale thermophoresis was used to analyse the direct binding of TLR4 to Gal-3, Gal-3 CRD, Gal-3 R186S, and Gal-3 in the presence of inhibitory lactose (40 mM). Whereas the concentration of fluorescently labelled TLR4 was kept constant, the non-labelled proteins were titrated (x axis), and the minimal and maximal Fnorm values of the unbound and bound state of TLR4, respectively, were used to calculate the percent of TLR4 bound to Gal-3 (y axis).
Fig. 1 Illustration from Burguillos et al. 2015 [31]: Gal-3 acts as a ligand to TLR4. Left panel: Colocalisation of Gal-3 and TLR4 in BV2 cells after 1 h exposure with sGal-3 protein. Right panel: Microscale thermophoresis was used to analyse the direct binding of TLR4 to Gal-3, Gal-3 CRD, Gal-3 R186S, and Gal-3 in the presence of inhibitory lactose (40 mM). Whereas the concentration of fluorescently labelled TLR4 was kept constant, the non-labelled proteins were titrated (x axis), and the minimal and maximal Fnorm values of the unbound and bound state of TLR4, respectively, were used to calculate the percent of TLR4 bound to Gal-3 (y axis).CC BY · PubMed Central
Fig. 2 Illustration from Boza-Serrano et al. 2019 [13]: Gal-3 interacts with TREM2. Left panel: Gal-3 and TREM2 in plaque-associated microglia in the brain of 5xFAD mice reveal colocalisation of Gal-3 and TREM2. Right panel: Gal-3 and TREM2 interaction in 5xFAD mouse brain using Stochastic Optical Reconstruction Microscopy (STORM). All images were taken in 5xFAD mice at 18 months.
Fig. 2 Illustration from Boza-Serrano et al. 2019 [13]: Gal-3 interacts with TREM2. Left panel: Gal-3 and TREM2 in plaque-associated microglia in the brain of 5xFAD mice reveal colocalisation of Gal-3 and TREM2. Right panel: Gal-3 and TREM2 interaction in 5xFAD mouse brain using Stochastic Optical Reconstruction Microscopy (STORM). All images were taken in 5xFAD mice at 18 months.CC BY · PubMed Central
Fig. 3 Illustration from Yip et al. 2017 [14]: effect of the lack of galectin-3 on the neuronal survival in cortex and hippocampus after TBI. Representative pictures of NeuN in different regions (left panel). Representative image of toluidine blue staining in wild-type and galectin-3 knockout mice (right panel). Note neuroprotection at 24 h and limited injury size 21 days after the TBI in Gal-3 KO mice. Scale bars are 100 and 1000 µm respectively.
Fig. 3 Illustration from Yip et al. 2017 [14]: effect of the lack of galectin-3 on the neuronal survival in cortex and hippocampus after TBI. Representative pictures of NeuN in different regions (left panel). Representative image of toluidine blue staining in wild-type and galectin-3 knockout mice (right panel). Note neuroprotection at 24 h and limited injury size 21 days after the TBI in Gal-3 KO mice. Scale bars are 100 and 1000 µm respectively.CC BY · PubMed Central
Fig. 4 Broad view of the role of Galectin-3 in microglia-associated neurodegenerative diseases. Galectin-3 (Gal-3) is one of the most highly expressed in Alzheimer’s Disease (AD) associated microglia (DAM) interacting with TREM2, TLR4 and MERTK. White matter-associated microglia (WAM) is also triggered by TREM2 activity but no role for Gal-3 has been yet uncovered. Gal-3 is found in the outer layer of the Lewy Bodies in neurons from Parkinson’s Disease (PD) patients, whereas internalisation of alpha-synuclein (αS) by microglia leads to the release of Gal-3 to the extracellular matrix. In Huntington’s Disease (HD) Gal-3 is known to be released by microglia leading to inflammasome pathway activation and cytokine release. In Multiple Sclerosis (MS) Gal-3 is released in response to demyelinization and known to interact with TREM2. In Amyotrophic Lateral Sclerosis (ALS) microglia release Gal-3 which exerts a neuroprotective role, but no mechanism nor ligands have been identified. In Stroke, Gal-3 present a dual role binding to TLR4 and IGF1R to increase cytokine production and microgliosis, but also promoting VEGF release and angiogenesis. In Traumatic Brain Injury (TBI), Gal-3 is highly released after the trauma and binds to TLR4 predominantly to promote an intense inflammatory reaction associated to cytokine release.
Fig. 4 Broad view of the role of Galectin-3 in microglia-associated neurodegenerative diseases. Galectin-3 (Gal-3) is one of the most highly expressed in Alzheimer’s Disease (AD) associated microglia (DAM) interacting with TREM2, TLR4 and MERTK. White matter-associated microglia (WAM) is also triggered by TREM2 activity but no role for Gal-3 has been yet uncovered. Gal-3 is found in the outer layer of the Lewy Bodies in neurons from Parkinson’s Disease (PD) patients, whereas internalisation of alpha-synuclein (αS) by microglia leads to the release of Gal-3 to the extracellular matrix. In Huntington’s Disease (HD) Gal-3 is known to be released by microglia leading to inflammasome pathway activation and cytokine release. In Multiple Sclerosis (MS) Gal-3 is released in response to demyelinization and known to interact with TREM2. In Amyotrophic Lateral Sclerosis (ALS) microglia release Gal-3 which exerts a neuroprotective role, but no mechanism nor ligands have been identified. In Stroke, Gal-3 present a dual role binding to TLR4 and IGF1R to increase cytokine production and microgliosis, but also promoting VEGF release and angiogenesis. In Traumatic Brain Injury (TBI), Gal-3 is highly released after the trauma and binds to TLR4 predominantly to promote an intense inflammatory reaction associated to cytokine release.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 151 references

Research works printed but not linked: 1

  1. Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep. 2015;10:1626–38. · DOI · Paper page

Cited by

See all 163

Metadata

Authors
García-Revilla, J., Boza-Serrano, A., Espinosa-Oliva, A. M., Soto, M. S., Deierborg, T., Ruiz, R., de Pablos, R. M., Burguillos, M. A., & Venero, J. L.
Affiliations
  • Instituto de Biomedicina de Sevilla (ES)
  • Lund University (SE)
Corresponding author
Venero, Jose L.
Venue
Cell Death & Disease
Published
2022-07-20
Volume
13
Issue
7
Pages
628-628
ISSN
2041-4889 (ISSN-L)
OpenAlex
W4286253573
Cited by
156
References
151
Citations by year
2026: 28 · 2025: 57 · 2024: 54 · 2023: 13 · 2022: 4
FWCI
3.32
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by-nc-nd)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Universidad de Sevilla (US-1264806)
  • Ministerio de Ciencia, Innovación y Universidades (RTI2018-098645-B-100, PID2019, PID2021-124096OB-I00, RYC-2017, FEDER/UE RTI2018-098645-B-100, RTI2018)
  • Lunds Universitet
  • Vetenskapsrådet (2019-06333)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
galectin-3, microglial activation, neurodegeneration, disease-associated microglia, pattern recognition receptors, TLR4, TREM2, lectins, neuroprotection, neurotoxicity, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, stroke
MeSH terms
Alzheimer Disease, Humans, Parkinson Disease, Microglia, Galectin 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration. https://app.cochat.ai/papers/10.1038/s41419-022-05058-3
The paper
García-Revilla, J., Boza-Serrano, A., Espinosa-Oliva, A. M., Soto, M. S., Deierborg, T., Ruiz, R., de Pablos, R. M., Burguillos, M. A., & Venero, J. L. (2022). Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration. Cell Death & Disease. https://doi.org/10.1038/s41419-022-05058-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.